Key facts
- IKKO Health’s last known valuation is $11.8M (Feb 2025).
- It has raised $13.4M; the latest was Early Stage VC ($4.7M) in Feb 2025.
- Notable investors include Innovation Authority, BRM Group, Arbelon Holdings.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for IKKO Health
- ·The full record, as it builds
Funding rounds
No funding rounds for IKKO Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IKKO Health
Developer of a medical imaging technology designed to enable safe, accessible, and cost-efficient diagnostic imaging. The company offers a wearable scanner paired with cloud-based imaging software that supports a per-image usage model and produces standard-format medical images, enabling healthcare providers and non-specialist operators to perform diagnostic imaging without specialized facilities or equipment while maintaining image clarity and consistency.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 14
- Website
- ikko.health/
- Ownership
- Privately Held (backing)
IKKO Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IKKO Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IKKO Health in its N-PORT filings yet. We sweep new filings monthly.